Investment incentive: €20 million to support pharma and biotech companies active in the fight against COVID-19

On the proposal of the Minister of the Economy, Willy BORSUS, the Government of Wallonia has approved the granting of an investment premium in favor of companies active in the manufacture of products related to COVID-19.

On the proposal of the Minister of the Economy, Willy BORSUS, the Government of Wallonia has approved the granting of an investment premium in favor of companies active in the manufacture of products related to COVID-19. A budget of €20 million has been mobilized for this measure. It should be noted that the European Commission has validated the mechanism.

This investment support, intended for SMEs and large companies with an establishment unit in Wallonia, will be granted for the manufacture of the following products: medicines (including vaccines) and medical treatments, their intermediary products, active pharmaceutical ingredients and raw materials as well as diagnostic tools.

Read the press release